Cite
MLA Citation
V. Santini et al.. “115 MDS-005 STUDY: EFFECT OF BASELINE ENDOGENOUS EPO ON RBC TRANSFUSION INDEPENDENCE (RBC-TI) IN LENALIDOMIDE-TREATED PATIENTS WITH LOW/INTERMEDIATE-1-RISK MDS WITHOUT DEL(5Q).” Leukemia research, vol. 39, n.d., pp. S59–. http://access.bl.uk/ark:/81055/vdc_100059908901.0x000001